Guenter Janhofer

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Brendan Hannah, Attorney-in-Fact for Guenter Janhofer, M.D., Ph.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Guenter Janhofer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. Chief Scientific Officer Common Stock 15,008 $14,108 $0.9400 23 Oct 2023 Direct
Quince Therapeutics, Inc. Chief Scientific Officer Employee Stock Option (right to buy) 300,000 23 Oct 2023 Direct

Insider Reports Filed by Guenter Janhofer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QNCX Quince Therapeutics, Inc. 23 Oct 2023 1 $0 4 Chief Scientific Officer 24 Oct 2023, 19:42
QNCX Quince Therapeutics, Inc. 23 Oct 2023 0 $0 3 Chief Scientific Officer 24 Oct 2023, 19:34